by admin | Mar 21, 2025 | News & Opinions
By Frank Vinluan – MedCity News – Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder....
by admin | Mar 20, 2025 | News & Opinions
By Mass General Brigham – A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace...
by admin | Mar 19, 2025 | News & Opinions
By Technology Networks – Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson’s treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking...
by admin | Mar 18, 2025 | News & Opinions
By Mass General Brigham – An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 months, and there was a...
by admin | Mar 17, 2025 | News & Opinions
By Technology Networks – A new, alternative treatment for wet AMD involves the transplantation of stem cell-derived retinal cells. Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In...
by admin | Mar 14, 2025 | News & Opinions
By Pharmaceutical Technology – AI can enhance the drug discovery process of regenerative medicine by tackling the primary challenges associated with the process. As the field of regenerative medicine continues to advance, the incorporation of AI is playing a...
